A Single and Multiple Ascending Dose Study of COR588

NCT04920903 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

64

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy Volunteers

Interventions

DRUG: COR588
DRUG: Placebo

Sponsor

Cortexyme Inc.